Piper Sandler Has Lowered Expectations for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CL) had its price target lowered by Piper Sandler from $121.00 to $112.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Piper Sandler’s price target suggests a potential upside of 28.28% from the company’s previous close.

A number of other equities analysts have also recently weighed in on the company. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Wednesday, January 1st. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. TD Cowen reduced their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $104.16.

Colgate-Palmolive Trading Down 0.3 %

NYSE CL opened at $87.31 on Monday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock’s 50-day simple moving average is $93.03 and its two-hundred day simple moving average is $98.31. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30. The company has a market capitalization of $71.33 billion, a price-to-earnings ratio of 25.02, a PEG ratio of 3.31 and a beta of 0.44.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of CL. Advisor OS LLC increased its holdings in shares of Colgate-Palmolive by 4.5% during the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock valued at $228,000 after acquiring an additional 101 shares in the last quarter. D Orazio & Associates Inc. increased its stake in Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares in the last quarter. Fiducient Advisors LLC increased its stake in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after purchasing an additional 110 shares in the last quarter. Wealthspire Advisors LLC lifted its stake in shares of Colgate-Palmolive by 3.0% in the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock worth $374,000 after buying an additional 111 shares in the last quarter. Finally, Sequoia Financial Advisors LLC grew its holdings in shares of Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after buying an additional 113 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.